Jochen Metzger
Rotenburger Str. 20
Hannover, NI 30659, Germany
Hannover, NI 30659, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Editorial: Mass spectrometry-based proteomics in drug discovery and development.
Journal: Frontiers in medicine
Published: June 12, 2024
Publisher Correction to: A universal predictive and mechanistic urinary peptide signature in acute kidney injury.
Journal: Critical care (London, England)
Published: December 29, 2022
Urinary collagen peptides: Source of markers for bone metabolic processes in kidney transplant recipients.
Journal: Proteomics. Clinical applications
Published: December 28, 2022
A universal predictive and mechanistic urinary peptide signature in acute kidney injury.
Journal: Critical care (London, England)
Published: June 30, 2022
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial.
Journal: Transplantation direct
Published: February 03, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.
Journal: The Lancet. Digital health
Published: January 11, 2022
Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma.
Journal: Cancers
Published: June 17, 2021
Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 18, 2021
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients.
Journal: EClinicalMedicine
Published: March 02, 2021
Urinary Proteomics Associates with COVID-19 Severity: Pilot Proof-of-Principle Data and Design of a Multicentric Diagnostic Study.
Journal: Proteomics
Published: July 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.
Journal: Leukemia
Published: June 17, 2020
Last Updated: 09/26/2026